NCT02166632View on ClinicalTrials.gov

Postoperative Pain Control Results Using Periarticular Versus Intra-capsular Injection of Bupivacaine Liposome Injectable Suspension in Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Osteoarthritis, Knee
Interventions
PROCEDURE

Intracapsular Injection

"The amount of bupivacaine liposome (ExparelTM) will be injected directly into the joint capsule (intracapsular injection), effectively bathing the joint in the medication."

PROCEDURE

Periarticular Injection

The amount of bupivacaine liposome (ExparelTM) will be injected periarticulary, via 9 standard periarticular tissue sites around the joint

Trial Locations (1)

33316

Broward Health Sports Medicine, Fort Lauderdale

Sponsors

Lead Sponsor

Broward Health
All Listed Sponsors
lead

Broward Health

OTHER

NCT02166632 - Postoperative Pain Control Results Using Periarticular Versus Intra-capsular Injection of Bupivacaine Liposome Injectable Suspension in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter